What is the P/E ratio of Metahelix Life Sciences . - (Amalgamated)?

The latest standalone P/E ratio of Metahelix Life Sciences . - (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Metahelix Life Sciences . - (Amalgamated)?

The latest standalone P/B ratio of Metahelix Life Sciences . - (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Metahelix Life Sciences . - (Amalgamated)?

The 52-week high of Metahelix Life Sciences . - (Amalgamated) is Rs. and the 52-week low is Rs. .

Metahelix Life Sciences Ltd. - (Amalgamated) - Stock Valuation and Financial Performance

Name: Metahelix Life Sciences . - (Amalgamated)
Brand: Metahelix Life Sciences . - (Amalgamated)

BSE: 0 | NSE: | Agriculture | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Metahelix Life Scien

Based on:

Data

M-Cap below 100cr DeciZen not available

Metahelix Life Sciences Ltd. - (Amalgamated) stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

0 Cr.

52-wk low:

52-wk high:

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Metahelix Life Scien:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
ROCE % ⓘ	2.6%	6.8%	5.5%	2%	20.8%	29.8%	20.4%	33.9%	22.9%	20%	-
Value Creation Index ⓘ	-0.8	-0.5	-0.6	-0.9	0.5	1.1	0.5	1.4	0.6	0.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	6.1	11.9	10.3	12.5	225	310	334	287	319	336	336
Sales YoY Gr.	-	93.6%	-13.2%	21.5%	1,698.5%	37.9%	7.8%	-14.2%	11.3%	5.4%	-
Adj EPS ⓘ	63.6	173.5	305.2	107.5	819.5	1,541.3	1,441.9	3,008	2,233.4	2,268.6	0
YoY Gr.	-	172.6%	75.9%	-64.8%	662.2%	88.1%	-6.5%	108.6%	-25.8%	1.6%	-
BVPS (₹) ⓘ	542.9	5,277.9	5,583.2	5,601	1,524.8	3,063.2	4,981.2	7,970.5	10,192.8	12,245.9	0
Adj Net Profit ⓘ	0.3	1.8	3.2	1.2	8.8	16.6	15.5	32.3	24	24.4	0
Cash Flow from Ops. ⓘ	-12.3	7.6	0.8	3.2	26.5	6.5	12.4	52.1	49.8	23.6	-
Debt/CF from Ops. ⓘ	-1.3	0.2	1.8	0.6	1.4	7.7	4.3	0.3	0.1	0.1	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	56.1%	8.4%	0.2%	5.4%
Adj EPS ⓘ	48.8%	22.6%	16.3%	1.6%
BVPSⓘ	41.4%	51.7%	35%	20.1%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
Return on Equity % ⓘ	1.4	4.3	5.6	1.9	23	67.2	35.9	46.5	24.6	20.2	0
Op. Profit Mgn % ⓘ	27.4	45.9	39.4	23.9	7.5	7.9	6.7	10.4	10.7	10.1	NAN
Net Profit Mgn % ⓘ	5.5	15.5	31.4	9.3	3.9	5.4	4.6	11.3	7.5	7.3	0
Debt to Equity ⓘ	0.6	0	0	0	2.3	1.5	1	0.2	0	0	-
Working Cap Days ⓘ	1,431	478	288	237	114	184	221	304	309	339	0
Cash Conv. Cycle ⓘ	341	99	141	160	44	74	93	101	77	93	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Metahelix Life Sciences Ltd. - (Amalgamated)

	Standalone	Consolidated
TTM EPS (₹)	0	-
TTM Sales (₹ Cr.)	336	-
BVPS (₹.) ⓘ	0	-
Reserves (₹ Cr.) ⓘ	132	-
P/BV ⓘ	0.00	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	- / -
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	0
Equity (₹ Cr.)	0
Face Value (₹)	10
Industry PE ⓘ	26.4

Management X-Ray of Metahelix Life Scien:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Metahelix Life Scien

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Metahelix Life Scien

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Sales	6.12	11.85	10.29	12.50	224.81	309.99	334.08	286.55	318.95	336.21
Operating Expenses ⓘ	4.46	6.41	6.23	9.51	208.07	285.48	311.87	256.81	285.02	305.69
Manufacturing Costs	0.57	0.79	0.24	0.30	3.30	4.37	5.42	6.25	17.62	20.33
Material Costs	0.14	1.35	1.03	1.53	93.98	130.14	136.86	149.07	155.50	171.03
Employee Cost	2.33	3.23	2.42	4.17	21.27	24.41	29.04	32.12	37.62	40.49
Other Costs ⓘ	1.42	1.04	2.54	3.52	89.51	126.57	140.55	69.37	74.28	73.83
Operating Profit ⓘ	1.66	5.44	4.05	2.99	16.75	24.51	22.21	29.74	33.92	30.53
Operating Profit Margin (%)	27.1%	45.9%	39.4%	23.9%	7.4%	7.9%	6.6%	10.4%	10.6%	9.1%
Other Income ⓘ	0.11	0.40	0.01	0.01	1.47	2.01	2.69	2	6.87	4.59
Interest ⓘ	0.90	2.33	0.04	0.06	4.55	5.34	5.64	4.70	1.05	0.40
Depreciation ⓘ	0.54	1.01	0.79	1.78	4.44	4.66	5.47	5.12	5.56	6.70
Exceptional Items ⓘ	0	0	0	0	0	0	6.81	0	0	0
Profit Before Tax ⓘ	0.33	2.51	3.23	1.16	9.23	16.52	20.62	21.92	34.19	28.02
Tax ⓘ	0	0.68	0	0	0	-0.02	0	-10.42	10.23	5.37
Profit After Tax	0.33	1.83	3.23	1.16	9.23	16.54	20.62	32.34	23.96	22.64
PAT Margin (%)	5.3%	15.5%	31.4%	9.2%	4.1%	5.3%	6.2%	11.3%	7.5%	6.7%
Adjusted EPS (₹)	61.5	173.3	305.3	107.5	858.1	1,538.4	1,918.0	3,008.0	2,228.5	2,106.5
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Equity and Liabilities
Shareholders Fund	28.89	55.81	59.04	60.21	16.39	32.93	53.55	85.68	109.57	131.64
Share Capital ⓘ	26.05	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11
Reserves ⓘ	2.83	55.70	58.93	60.10	16.28	32.82	53.44	85.58	109.46	131.54
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	16.30	1.39	1.47	1.64	35.50	48.33	51.63	15.62	1.97	1.14
Long Term Debt	16.30	1.39	1.47	1.64	3.55	7.36	5.13	3.23	1.97	1.14
Short Term Debt	0	0	0	0	31.96	40.97	46.49	12.39	0	0
Trade Payables	0.69	0.93	1.02	1.15	64.83	81.97	85.78	100.45	160.77	177.04
Others Liabilities ⓘ	1.30	1.23	1.06	1.20	47.70	56.13	76.75	100.56	91.43	117.52
Total Liabilities ⓘ	47.18	59.36	62.59	64.20	164.42	219.36	267.71	302.31	363.75	427.35
Fixed Assets
Gross Block	9.92	14.39	9.41	14.60	36.87	44.56	49.55	37.66	42.75	49.62
Accumulated Depreciation	4.36	5.37	5.60	7.38	15.28	19.49	24.10	10.47	16	22.52
Net Fixed Assetsⓘ	5.56	9.02	3.81	7.22	21.59	25.07	25.45	27.19	26.76	27.10
CWIP ⓘ	0.64	0.67	9.51	7.89	7.97	12.09	16.53	19.06	22.64	26.08
Investmentsⓘ	16.01	41.01	41.01	41.01	0	0	0	0.82	2.04	30.77
Inventories	1.53	1.85	3.35	4.21	89.78	116.25	147.45	150.53	198.55	244.20
Trade Receivables	4.61	2	3.79	2.42	31.03	41.29	42.55	39.72	36.03	33.32
Cash Equivalents	0.18	0.59	0.10	0.04	2.10	2.02	1.61	1.76	25.75	6.24
Others Assetsⓘ	18.65	4.21	1.02	1.40	11.95	22.65	34.10	63.23	51.98	59.64
Total Assets ⓘ	47.18	59.36	62.59	64.20	164.42	219.36	267.71	302.31	363.75	427.35

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Cash Flow From Operating Activity ⓘ	-12.31	7.57	0.82	3.22	26.45	6.46	12.41	52.07	49.75	23.63
PBT ⓘ	0.33	2.51	3.23	1.16	9.23	16.52	20.62	21.92	34.19	28.02
Adjustment ⓘ	1.42	3.33	1.20	1.83	11.18	11.36	13.20	16.34	12.53	14.13
Changes in Working Capital ⓘ	-14.23	2.41	-3.6	0.71	8.73	-18.26	-15.86	21.54	11.31	-7.11
Tax Paid ⓘ	0.17	-0.68	0	-0.48	-2.69	-3.17	-5.54	-7.72	-8.28	-11.40
Cash Flow From Investing Activity ⓘ	-4.77	-15.02	-1.41	-3.57	-12.13	-14.11	-11.19	-12.23	-11.61	-42.75
Capex	-3.46	-4.50	0	0	0.80	0.01	0.01	-11.56	-11.11	-12.12
Net Investments	0	0	0	0	0	0	0	-0.82	-0.50	-30.63
Others ⓘ	-1.32	-10.52	-1.41	-3.57	-12.94	-14.12	-11.20	0.16	0	0
Cash Flow From Financing Activityⓘ	15.12	7.86	0.10	0.29	-14.73	7.44	-1.64	-39.69	-14.15	-0.39
Net Proceeds from Shares ⓘ	0	25.09	0	0.02	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	16.32	-15.90	0	0	1.23	3.94	-1.60	0	0	0
Interest Paid ⓘ	0	0	-0.01	-0.05	-4.64	-5.50	-5.57	-4.77	-1.01	-0.39
Dividend Paid ⓘ	-1.21	-2.33	0	0	0	0	0	0	0	0
Others ⓘ	0	1	0.11	0.32	-11.31	9.01	5.53	-34.92	-13.14	0
Net Cash Flow ⓘ	-1.97	0.41	-0.49	-0.06	-0.41	-0.21	-0.41	0.15	23.99	-19.51

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Ratios
ROE (%)	0	6.24	5.62	1.94	24.09	67.06	47.69	46.45	24.54	18.78
ROCE (%)	3.32	9.45	5.56	1.98	23.88	32.1	27.6	25.29	32.61	23.05
Asset Turnover Ratio	0.17	0.24	0.17	0.2	1.97	1.62	1.37	1.01	0.96	0.85
PAT to CFO Conversion(x)	-37.3	4.14	0.25	2.78	2.87	0.39	0.6	1.61	2.08	1.04
Working Capital Days
Receivable Days	341	96	103	91	27	43	46	52	43	38
Inventory Days	86	49	92	110	76	121	144	190	200	240
Payable Days	1,562	220	344	258	128	206	224	228	307	360

Metahelix Life Sciences Ltd. - (Amalgamated) Stock News

Metahelix Life Sciences Ltd. - (Amalgamated) FAQs

What is the share price of Metahelix Life Scien?

Company share prices are keep on changing according to the market conditions. The closing price of Metahelix Life Scien on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Metahelix Life Scien?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Metahelix Life Scien stood at ₹0.00.